Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
4,380,098
-
Shares change
-
+535,205
-
Total reported value, excl. options
-
$16,755,945
-
Value change
-
+$2,234,312
-
Number of buys
-
29
-
Number of sells
-
-15
-
Price
-
$3.84
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q2 2020
54 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2020.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,380,098 shares
of 126,273,814 outstanding shares and own 3.5% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,062,383 shares), Prosight Management, LP (535,616 shares), GEODE CAPITAL MANAGEMENT, LLC (368,263 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (350,280 shares), VANGUARD GROUP INC (306,558 shares), NORTHERN TRUST CORP (279,144 shares), HUSSMAN STRATEGIC ADVISORS, INC. (200,000 shares), STATE STREET CORP (194,521 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (149,480 shares), and RENAISSANCE TECHNOLOGIES LLC (134,500 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.